Get the latest tech news
COVID-19 Vaccine's mRNA Technology Adapted for First Antibiotic-Resistant Bacteria Vaccine
Researchers have created the world's first mRNA-based vaccine against a deadly, antibiotic-resistant bacterium — and they did it using the platform developed for COVID-19 vaccines. Medical Express publishes their announcement: The vaccine developed by the team from the Institute for Biologic...
They chose Yersinia pestis, the bacterium that causes bubonic plague — a disease responsible for deadly pandemics throughout human history. In animal models, the researchers demonstrated that it is possible to effectively vaccinate against the disease with a single dose. The team of researchers was led by Professor Dan Peer at Tel Aviv University, a global pioneer in mRNA drug development, who says the success of the current study now "paves the way for a whole world of mRNA-based vaccines against other deadly bacteria."
Or read this on Slashdot
